Hepatitis C remains the main etiology of hepatocellular carcinoma among liver transplant recipients in the United States in the direct-acting antiviral era

被引：0
|
作者：
Saberi, B. [1 ]
Hashim, D. [1 ]
Dinani, A. [1 ]
Asgharpour, A. [1 ]
Kushner, T. [1 ]
Tabrizian, P. [1 ]
Schwartz, M. [1 ]
Dieterich, D. [1 ]
Llovet, J. M. [1 ]
Boffetta, P. [1 ]
Friedman, S. L. [1 ]
Gurakar, A. [2 ]
机构：
[1] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[2] Johns Hopkins Comprehens Transplant Ctr, Baltimore, MD USA
来源：
TRANSPLANTATION | 2019年 / 103卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P-438
引用
收藏
页码：312 / 312
页数：1
相关论文
共 50 条
  • [31] Improved Post-Transplant Outcomes for Hepatocellular Carcinoma in Direct-Acting Antiviral Therapy Era
    不详
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 57 - 57
  • [32] Evaluation of Hepatitis C Patients in the Direct-Acting Antiviral Era
    Teriaky, Anouar
    Reau, Nancy
    CLINICS IN LIVER DISEASE, 2015, 19 (04) : 591 - +
  • [33] The Hepatitis C Care Cascade During the Direct-Acting Antiviral Era in a United States Commercially Insured Population
    Ferrante, Nicole D.
    Newcomb, Craig W.
    Forde, Kimberly A.
    Leonard, Charles E.
    Torgersen, Jessie
    Linas, Benjamin P.
    Rowan, Sarah E.
    Wyles, David L.
    Kostman, Jay
    Trooskin, Stacey B.
    Lo Re, Vincent
    OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (09):
  • [34] Liver transplant listing for hepatitis C-associated cirrhosis and hepatocellular carcinoma has fallen in the United Kingdom since the introduction of direct-acting antiviral therapy
    Vaziri, Arash
    Gimson, Alexander
    Agarwal, Kosh
    Aldersley, Mark
    Bathgate, Andrew
    MacDonald, Douglas
    McPherson, Stuart
    Mutimer, David
    Gelson, William
    JOURNAL OF VIRAL HEPATITIS, 2019, 26 (02) : 231 - 235
  • [35] Outcome of hepatitis C-related liver transplantation in direct-acting antiviral era
    Choudhary, Narendra S.
    Saraf, Neeraj
    Saigal, Sanjiv
    Rastogi, Amit
    Bhangui, Prashant
    Thiagrajan, Srinivas
    Soin, Arvinder S.
    INDIAN JOURNAL OF GASTROENTEROLOGY, 2020, 39 (06) : 539 - 543
  • [36] CHANGING POPULATION OF LIVER TRANSPLANT RECIPIENTS IN THE ERA OF DIRECT ACTING ANTIVIRAL THERAPY FOR HEPATITIS C VIRUS INFECTION
    Xie, Chencheng
    Abdallah, Mohamed
    Wong, Robert J.
    Kwo, Paul Yien
    Thuluvath, Paul
    Asrani, Sumeet K.
    Singal, Ashwani K.
    HEPATOLOGY, 2019, 70 : 679A - 679A
  • [37] Prediction of hepatocellular carcinoma following direct-acting antiviral treatment for chronic hepatitis C
    Nishino, Ken
    Kawanaka, Miwa
    Tanikawa, Tomohiro
    Urata, Noriyo
    Oka, Takahito
    Nakamura, Jun
    Suehiro, Mitsuhiko
    Sasai, Takako
    Kawamoto, Hirofumi
    HEPATOLOGY, 2017, 66 : 554A - 554A
  • [38] Impact of direct-acting antiviral therapy for hepatitis C-related hepatocellular carcinoma
    Lin, Wei-Chen
    Lin, Yang-Sheng
    Chang, Chen-Wang
    Chang, Ching-Wei
    Wang, Tsang-En
    Wang, Horng-Yuan
    Chen, Ming-Jen
    PLOS ONE, 2020, 15 (05):
  • [39] Association Between Hepatocellular Carcinoma and Hepatitis C Direct-Acting Antiviral Treatment Failure
    Le Roux, Michelle
    Civan, Jesse
    Fenkel, Jonathan M.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S1581 - S1582
  • [40] Interaction Between Hepatocellular Carcinoma and Hepatitis C Eradication With Direct-acting Antiviral Therapy
    Venkata Rajesh Konjeti
    Binu V. John
    Current Treatment Options in Gastroenterology, 2018, 16 (2) : 203 - 214
12345